GTx regains compliance with Nasdaq bid price rule
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Biopharmaceutical company GTx Inc. regained compliance with the Nasdaq rule requiring a minimum $1 bid price per share for continued listing on the Nasdaq Capital Market.
Nasdaq notified the company of its noncompliance with the rule on Dec. 5, prompting the company to implement a reverse stock split.
With the company regaining compliance, Nasdaq has now closed the matter.
